Document dnN87gxqnMN7OB4G3gKxdK2r9
British Journal of Industrial Medicine 1986;43:227-236
Cancer incidence among workers in the Norwegian ferroalloy industry
H KJUUS,1 A ANDERSEN,2 S LANGARD,' AND K E KNUDSEN3
From the Department ofOccupational Medicine, 1 Telemark Sentralsjukehus, N-3900 Porsgrunn, the Cancer Registry ofNorway,2 Montebello, Oslo 3, and the Health Board ofthe Norwegian Ferroalloy Industry,3 Fiskaa
Verk, Kristiansand S, Norway
ABSTRACT The total mortality and the incidence of cancer was studied among a cohort of employees at the six oldest ferrosilicon and ferromanganese plants in Norway. The cohort consisted of 6494 men employed for more than 18 months before 1970 and has been followed up from 1953 to 1982. The standardised incidence ratio (SIR) for cancer (all sites) was 0-94. The observed number of cancers was as expected for lung cancer (SIR = 0 99) and for most of the other cancer sites studied. A statistically significant reduction of stomach cancer was found (SIR = 0 72). There was an increased incidence of lung cancer (SIR = 1-75) and cancer of the prostate (SIR = 1 56) in the workers at one ferrosilicon plant and of colonic cancer (SIR = 1 90) at another ferrosilicon plant.
Ferroalloys are alloys of iron and another metal,
most commonly chromium, manganese, or silicon. They are used as a vehicle for introducing specific elements into the manufacture of steel in order to produce steel with specific properties. Ferrochromium is used in converting steel to stainless steel. Ferromanganese imparts strength, toughness, and hardness to steel and the ferrosilicons act mainly as "metal cleaners" by removing oxygen from the molten steel.
The emissions from the ferroalloy production pro-
cesses consist of a complex mixture of particles, fumes, and chemicals, depending on which alloy is
produced.' 2 The electrothermal reduction of iron
containing ores with carbon as the reduction agent, however, is common to the whole industry. Irrespective of the alloy produced, the ferroalloy process implies exposure to combustion products, among which the polycyclic aromatic hydrocarbons (PAH) are considered to be of particular interest for human health.
The production of ferroalloys is an energy consuming process, and Norway has the advantage of easy access to hydroelectric power. Of the 50 ferroalloy plants in Western Europe, 14 are located in Norway. With approximately 10% of the world production, Norway is an important ferroalloy producer. Today these 14 plants produce 1 070 000 tons of ferroalloys a year and employ 5000 workers.
As to the possible health hazards associated with
Accepted I July 1985
the production of ferroalloys, silicosis due to
exposure to crystalline and amorphous silica has been noted,34 as has manganese poisoning, with Parkinson like symptoms, among employees producing manganese alloys.56
In regard to exposure to known carcinogens in the
ferroalloy industry, asbestos has been regularly used in the maintenance of the furnaces. The production of
ferrochromium has also been the object of particular interest, and epidemiological studies in ferrochromium plants in Norway and Sweden have shown
an excess of lung cancer associated with exposure to ferrochromium7 and asbestos related maintenance work.8 There are, however, epidemiological studies of cancer in workers producing ferroalloys other than ferrochromium7 (J Alexander et al, paper given at XX International Conference on Occupational
Health, Cairo, 1981). In 1973-5 a pilot project on the incidence of cancer
among employees from three Norwegian ferroalloy plants was performed in cooperation with the Norwegian Cancer Registry. No excess of lung cancer was shown in this study (8 cases observed against 8-8 expected) but a possible excess of urogenital cancer
was observed.
In the light of this finding the Health Board of the Norwegian Ferroalloy Industry initiated an epidemiological study comprising all ferroalloy plants in Norway, and we present the results from the six oldest
plants.
227
228 Table I Characterisation of the subcohorts Plant Year ofproduction start Main production
A 1918 B 1910 C 1907
D 1910 E 1915 F 1923
FeSi, Si-metal, anode paste
FeSi FeSi, calcium carbide FeMn,SiMn FeMn, FeSi FeMn, SiMn
Kjuus, Andersen, Langoird, and Knudsen
Personal records availablefrom
1918 1910 1920 1912 1915 1915
Start ofsubcohorts
(persons employed)
From 1918 From 1910 In 1930 From 1930 From 1915 From 1923
Production process
Measurements of dust levels
Table 1 gives a historical summary of the major pro-
ducts manufactured at the six study plants. Plants A, B, and C have mainly produced ferrosilicon (FeSi)
and silicon metal (Si-metal), with additional production of calcium carbide at plant C in previous years. Plants D and E have traditionally produced
ferromanganese (FeMn) and silicomanganese (SiMn) in combination with FeSi; plant F has produced only
manganese alloys.
All plants have used the Soderberg electrode, which consists of calcinated anthracite and a binder of tar and pitch. For the production of Si-metal, prebaked
carbon electrodes have been used. In the early years of production several plants produced their own electrode paste, but for the past 15 years plant A has produced anode paste for the other plants. FeSi has been produced in open ovens for the whole study period, while the ferromanganese ovens were gradually enclosed from 1953 onwards. In the past decade specific alloys have been produced continuously in the same furnaces, but previously any furnace could be
used to produce any other alloy as required. FeSi has been made mainly from quartz and scrap
metal or forge scales, with coke or coal as the reduction agent. It is produced in different grades according to the content of silicon (45%, 75%, and 90%), and the alloy usually contains low amounts of calcium, magnesium, phosphorus, and aluminium. FeSi
must remain dry during storage and transport, as contact with moisture leads to the formation of phosphine and arsine. In earlier years several deaths occurred from phosphine/arsine intoxication on ships
transporting ferrosilicon from ferroalloy plants.9 FeMn, which contains 78-90% manganese, is
made from manganese containing ores and coke, with quartz and limestone as slag producers. The slag is used as a raw material for the production of SiMn, by which the manganese content is increased from 80%
to 90%. Crushing and sieving of the castings were mainly performed by hand before 1955-60 and there is still some manual sorting of manganese alloys.
During the past 30 years, the change from manual to machine handling of raw materials and alloys, together with the enclosure of furnaces and improved ventilation, have -7radually reduced the individual worker's exposui co dust and fumes. The concentrations of dust in the working atmosphere in previous years are not known, as valid measurements have been performed only during the past 15 years. Even so, a substantial part of the measurements in several of the plants around 1970 indicates mean concentrations of total dust higher than 5 mg/m3, with many values between 10 and 30 mg/m3. The proportion of dust particles with diameter below 5 gm has been measured as 25-65% by weight.
Manganese dust measurements at plant F in 1979 were between 0 5 and 2 mg/m3. Only a few measurements of PAH have been performed in connection with the preparation of tapping spouts at the furnaces. These sporadic measurements, which have been in the range of 3-49 gg/M3 (10 pg/M3 TWA), indicate that the PAH exposure in the study plants has been substantially lower than in coke plants,'0 and also lower than that reported from the Norwegian aluminium industry," which also makes use of the Soderberg electrode.
In previous years asbestos has been regularly used at the plants, mainly by the maintenance staff, for heat protection and insulation around the furnaces. The amount used before 1965 is not known but in 1965-75 a mean consumption of 5000 kg/year/plant has been estimated. Altogether in 1981 the Norwegian ferroalloy industry used 25 tons of asbestos, of which 15 tons were used around the furnaces.
Material and methods
MATERIAL
The initial purpose of the project was to study the incidence of cancer in all the 14 Norwegian ferroalloy plants. Two plants producing ferrochromium and ferrovanadium had recently been subjected to separate
Cancer incidence among workers in the Norwegian ferroalloy industry
229
a personal register of persons employed in 1930 and
later.
Location of the six study plants in southern Norway.
epidemiological studies7 (J Alexander, Cairo conference) and were not included in this study. One plant was also excluded because it was not possible to obtain complete information on former employees. Five of the plants established after 1960 were also omitted from this& part of the project owing to the short follow up period. The present study, therefore, relates to the six oldest ferroalloy plants in Norway, all established before 1920. Plants A, C, D, and E are in small towns and plants B and F in rural areas of southern Norway (figure).
The plants provided information on former employees as far back as possible. As the oldest segment of a cohort is particularly vulnerable to outcome selective drop out, an individual starting date for each subcohort was chosen, from the time at which the personnel register at the plant was considered to be complete. Initially some plants provided information of former employees back to the 1950s only. By going back to older archives and personnel registers at the plants, old "cohort segments" were added to the initial subcohorts, making many of them complete from the year production started. Table I gives the starting date for each subcohort, varying from 1910 to 1930. Five of the subcohorts have been formed as inception cohorts, with workers employedfrom a certain date, whereas the subcohort from plant C may be considered as a cross sectional cohort,2 13 as it is based on
METHODS
Since 1 -January 1953 all new cases of cancer in Norway have been recorded by the Cancer Registry of Norway. This registration is based on compulsory reporting by hospital departments and histopathological laboratories and on death certificates reported by the Central Bureau of Statistics.
In 1960 all individuals in Norway were given a personal identification number, which has since been given to all inhabitants at birth or at immigration. Those in the cohort who developed cancer in the observation period were identified in the cancer registry by this personal identification number. For 1953-60 the identification of the cases of cancer had
to be done manually, whereas since 1960 this matching of the cases of cancer has been fully automated.
On the personnel lists provided by the plants about 6500 had no personal identification numbers. Most of these were traced through different sources, leaving 742 or 6% of the total cohort unidentified by personal identification number. Most of these came from the oldest segment of the cohort, whereas wrong date of birth or mis-spelled names could be other reasons for failing to identify them.
Of the 11 921 workers available for the study, all 416 women were excluded, together with the 742 unidentified and 21 with incomplete employment data. The 4248 workers employed after I January 1970 or for a shorter period than 18 months were also excluded, leaving a final study cohort of 6494 (table 2).
The observation period for the cohort was 30 years, from 1953 to the end of 1982. All those alive in 1953 were observed for occurrence of cancer from that year to the year of death or to the end of the observation period. Those employed later than 1953 were considered "under observation" from the middle of the year they were first employed.
Table 2 Summary of theformation ofthe cohort, employees from all six plants
Initial number of personal records: Duplicates Women Unidentified men Incomplete employment data Employed after I January 1970 or less than 18 months
Ultimate cohort
1610 416 742
21 4248
No 13 531
6494
230
The observed number of cases of cancer in the cohort was compared with the incidence of cancer of the total male Norwegian population. The five year age specific incidence rates for each year 1953-82 was used for this comparison. Standardised mortality ratios (SMRs) have been computed for overall mortality and standardised incidence ratios (SIRs) for selected cancer sites. For observed values < 100, the deviation of an SIR from I 00 was tested assuming a Poisson distribution for the observed number of cancer cases, using a two sided test of significance. For observed values > 100, two sided p values have been based on the usual large sample chi-square statistic
(X2 = (O-E)2/E) with test based 95% confidence
intervals (95% CI), as suggested by Miettinen.'4
OCCUPATIONAL CATEGORIES
Each plant used its own personnel register to compile a list of all employment periods for present and former employees with employment time exceeding six months. The total number of years employed was then calculated for each person. For those classified as "working at present" at the time the lists were completed (1977), employment time was calculated up to 31 December 1981 or to the time of retirement (67 years).
Job characterisation for each worker was based on information from three different sources. The main source was the personnel list from the plants, which provided information on the place of work within the plant, or occupational title for the longest job held at the plant. Some plants gave detailed information on the different tasks performed by each individual worker, whereas most plants provided information only on the main occupational title or place of work for the job held longest at the working plant. Information on job title or place of work was lacking for about 10% of the former employees. Experienced people from the personnel departments together with retired worker "veterans" managed to identify job title or main place of work for most of these. The occupational health service at the plants could give
Kjuus, Andersen, Langard, and Knudsen
additional information from old health records on the place of work for some of the workers. Altogether 217 workers, or 3% of the cohort, could not be identified by job title or main place of work. Most of these workers had been employed for shorter periods in the 1920s and 1930s.
Ten different occupational categories were defined. In general, the classification was made according to the place of work where the person had worked the longest time. If he had been working 10 years or more at the furnaces, however, he was classified as "furnace worker" irrespective of other jobs of longer duration. In one subcohort (plant F) information about the type of maintenance work performed was not available. All 337 maintenance workers from this plant have therefore been allocated to the occupational category "maintenance, other."
Interchange of workers between FeMn production and FeSi production was common in previous years at the two plants producing both alloys (plants D and E). Thus, except for a small subcohort producing FeMn at plant E after 1963, it was not possible to distinguish between those who had been working mainly in the FeMn production and FeSi production respectively.
Results
Table 3 shows the distribution of the men and the person-years in the cohort by plant together with the total mortality during the observation period. Among 6494 men there were 1935 deaths from all causes compared with 2150-3 expected. The overall SMR was 0-90, varying from 0-82 to 1 01 between the plant subcohorts.
In 1953-82 634 new cases of cancer were observed against 674-1 cases expected, which gives a SIR of 0 94 (table 4). There was no statistically significant excess of any of the cancers under study. The highest SIR observed was for sinonasal cancer (based on 5 observed cases and 2-7 expected) and for malignant
melanoma (O/E = 18/14-6); neither of these results
Table 3 Observed and expected total mortality among employees at sixferroalloy plants during thefollow up period, 1953-82
Plant No
Total mortality
employed
Observed
A B C D E F
Total
983 918 632 773 1161 2027
6494
242 303 292 248 241 609
1935
*p < 0-05, **p < 0-01. tStandardised mortality ratio.
t95% confidence interval.
Expected
245-3 367-6 290.2 2548 2828 7096
2150-3
SMRt
0 99 0-82** 1-01 0-97
0.85*
0.86**
090**
95% Cl1
(0-87-1-12)
(0-73-0-92) (0-89-113)
(086-110) (075-097) (079-093)
(0-86-094)
Person-years
22 263 21 966 13658 17378 26730 49679
151674
Cancer incidence among workers in the Norwegian ferroalloy industry
231
Table 4 Observed and expected number ofselected types ofcancer among 6494 employees at sixferroalloy plants, 1953-82
Cancer site (ICD, 8th revision)
Stomach (151) Colon (153) Rectum (154) Pancreas (157) Sinonasal (160) Lung (162, 163) Malignant melanoma (172) Prostate (185) Bladder (188) Kidney (189) Brain (191) Leukaemia(204-207) Other sites All cancer (140-209)
p < 0-01.
Observed
64 56 35 28 5 77 18 125 34 21 8 15 148
634
Expected
89-0 50-6 32-7 27-3 2-7 77-7 14-6 125-8 38-3 23-3 13-4 19-9 158-8
674-1
SIR
0.72* 1-11 1-07 103 1-85 0-99 1-23 0-99 0-89 0-90 0-60 0-75 0-93
0-94
95% CI
(0-55-0-92) (0 84-1-44) (0 75-1 49) (0-68-1-48) (0-59-4-33) (0-78-1-24) (0-73-1-95) (0-75-1-31) (0-62-1.24) (056-1-38) (0-26-1-18) (0-42-1-24) (0-79-1-10)
(0-87-1-02)
Table5 Observed (O) andexpected (E) casesofcanceramongemployeesateachofthesixferroalloyplants, 1953-82,by
plant
Plant Cancer sites
SIR 95% Cl
Lung Stomach (ICD 162, 163) (ICD 151)
0E0E
A 17 B9 C 12 D9 E 10 F 20
Total 77
*p < 0-05.
9.7* 6 13-1 14 8-7 7 9-3 6 11-7 8 25-2 23
77-7 64
9-8 16-0 11-2 10-3 11-6 30-1
89.0*
Colon (ICD 153)
0E
5 5-8 12 .8-9 1 1 5.8* 9 5-9 5 7-1 14 17-1
56 50-6
Prostate
(ICD 185)
All sites
(ICD 140-209)
0E0
E
20 12.8* 98 23 23-3 100 14 15-6 83 10 14-4 68 9 16-2 77 49 43-5 208
125 125-8 634
78-5 117-6 78-7 78-6 95-1 225-6
674-1
1.25* 0-85 1-06 0-87 0-81 0-92
0-94
(1-01-1-52) (0-69-1-03) (0-84-1-31) (0-67-1-10) (0-64-1-01) (0-80-1-06) (0-87-1-02)
Table 6 Observed (0) and expected (E) cases ofselected types ofcancer among 6494 employees at sixferroalloy plants, 1953-82, by occupational category
Occupational
category
No
employed
Cancer site
Lung (ICD 162, 163) 0E
Stomach (ICD 151)
0E
Colon (ICD 153)
0E
Prostate (ICD 185)
0E
All sites
(ICD 140-209)
0E
Furnace
2449
Maintenance, furnace 219
Maintenance, other 842
Quay, store, packing 797
Transport
289
Laboratory
143
Construction, various
jobs 954
Anodepasteplant 117
Office, administration 467
Unspecified
217
*p < 0-05.
29 1 10 7 5
13 3 2 6
29-6 25 2-8 3 7-3 4
11-1 14 3-5 2
0-9 1
13-0 10
1-4 0 4-9 4 3-2 1
34-0 21 3-0 2
8-6 9 12-6 10 4-0 1 1-0 1
15-2 10 1-5 0
5-8 1
3-3 1
19-1 47 1-7 0 4-8 14 9-0 23 1-6 9 0-6 2
8-6 18 01 3-3 9 1-9 2
47-9 241 3-9 13 11-2 67 18-7 88 6-1 28 1-3 10
22-2 107 2-1 13 7-9 43 4-5 24
255-4
23.6* 64-0 96-2 31-4 8-0
113-9 11-7 43-5 26-4
was statistically significant. There were 77 cases of lung cancer in the total cohort versus 77-7 expected (SIR = 0-99). The only statistically significant SIR observed was for stomach cancer, which was lower
than expected (SIR = 0 72). When considering some selected cancers in the
respective plant subcohorts, there was an excess of
lung cancer (O/E = 17/9 7) and cancer of the prostate (O/E = 20/12-8) among employees at one of the ferrosilicon plants (plant A) and of colonic cancer (O/E = 11/5-8) at plant C, where ferrosilicon and calcium carbide have been produced (table 5). All these findings are of borderline statistical significance.
The distribution of selected cancers by
232 Kjuus, Andersen, Langird, and Knudsen
Table 7 Incidence ofcancer at selected sites among employees at sixferroalloy plants, 1953-82, according to duration of
employment. (Observed (0) number ofnew cases and SIR)
Cancer site Lung (ICD 162,163) Stomach (ICD 151) Colon (ICD 153) Prostate (ICD 185) Cancer, all sites (ICD 140-209)
Years employed
15-4 5-14
15-24 > 25
Total
0 SIR 0 SIR 0 SIR 0 SIR 0 SIR
20 1 16 17 0-89 12 0-83 28 0-98 77 099 9 0-52 16 0-78 10 0-62 29 0-80 64 0-72
8 0-78 15 1-26 12 1-28 21 102 56 1 11 12 0-54 22 0 79 27 1-16 64 1-07 125 0 99 111 0-79 150 0 93 121 0 98 252 0 94 634 0 94
Table 8 Observed (0) and expected (E) cases oflung cancer among employees at plant A, by occupational category
Occupational category
Observed
Expected
SIR
Years employed
Furnace Maintenance Quay, store, packing Transport Anode paste plant Various jobs Office, administration
Total
5 1 1 3 3 2 2
17
*95% confidence interval: 10-2 8.
2-7 1 85 03,05,06, 12, 18 18 - 12 0-8 - 25 1-3 2 31 03,03,04 1-1 2-72 13, 19, 38 0-8 2-50 03, 15 1-2 1 67 21, 22
9-7 1-75*
Table 9 Total mortality and incidence ofcancer, all sites (ICD 140-209), among employees at sixferroalloy plants, 1953-82, according to period ofentry
Period ofentry
1910-29 1930-39 1940-49 1950-59 1960-69 Total
No ofdeaths, all causes
Observed
Expected
738 826-8 251 227-9 432 475-7 363 410-4 151 159-5
1935 2150-3
SMR
0-89 0 90 0.91 0-89 0 95
0 90
Cancer, all sites (ICD 140-209)
Observed
Expected
208 228-0 101 93-1 149 157 4 132 137-4 44 58-2
634 6741
SIR
0 91 1-08 0.95 0-96 0-76
0-94
occupational category is summarised in table 6. There was no excess of lung cancer among furnace workers or maintenance workers. Among workers at the anode paste plants, which implies definite exposure to PAH, there were three observed cases of lung cancer against 1[4 expected. The small number of men in several of the occupational categories, however, prevents any useful interpretation of many of the numbers given for the separate cancer sites.
Table 7 shows the SIRs for selected cancer sites
according to cumulative employment time. For lung cancer, the highest SIR was observed among those with the shortest employment time (SIR= 1 16),
whereas for the other cancer sites the lowest SIRs were observed in this group. No obvious dose response relation, however, was observed for any of
the cancer sites.
The observed excess of lung cancer at plant A
(SIR = 1-75) was related to several occupational categories (table 8). There were five cases of lung cancer among the furnace workers versus 2-7 expected. The three cases of lung cancer among the anode paste plant workers (1 1 expected) were all from plant A, and all of them were long term employees. There was no definite increase in SIR for lung cancer with employment time in this subcohort (not shown in the table).
Table 9 shows the total mortality and incidence of all cancers according to year of first employment. There was no trend in SMR or SIR from the older to
the more recent employment periods. When the material was further stratified according to both period of entry and years since first employment, the highest SIRs for cancers of the lung, stomach, and colon were seen for the follow up period 25-34 years, and-in particular among those employed before 1950 (table 10).
Cancer incidence among workers in the Norwegian ferroalloy industry
233
Table 10 Incidence ofcancer at selected sites among employees at sixferroalloy plants, 1953-82, according to period ofentry and years since.first employment. (Observed number ofcases (0) and SIR)
Cancer site Lung Stomach Colon Prostate
Period ofentry
1910-29 1930-39 1940-49 1950-59 1960-69 Total 1910-29 1930-39 1940-49 1950-59 1960-69 Total 1910-29 1930-39 1940-49 1950-59 1960-69 Total 1910-29 1930-39 1940-49 1950-59 1960-69 Total
Years sincefirst employment
15-14
15-24
0 SIR 0 SIR
1 278 2 0 61 3 0-71 8 0-94 7 1-35 3 1-06
10 0-98 14 0-93
2 0 99 3 0-68 4 0-67 4 0-61
1 0 61
6 050 8 059
1 1-70 5 2-51 2 0-83 5 1-02 1 0-36 1 0 65 4 0 70 1 1 1-28
1 2 70 5 1-22 5 1-23 14 1-29 2 0-43 1 0 37 7 073 21 1-16
25-34
0
4 2 12 5
23 2 4 9 3
18 3 1 8 3
15 3 1 9 7
20
SIR
3-48 1-33 1-33 1 01
1-38 0.59 1-74 1-26 0.95
1-12 3 70 110 1-60 1-05
1-57 1-94 0-47 0-81 1.19
095
35
0 SIR
15 0-82 11 1-16 4 0-52
30 0-84 20 0-62 9 1-03 3 0-52
32 068 14 0-86 8 141 4 095
26 0 99 53 100 21 1-39 2 0-22
1 77 100
Total
0 SIR
19 0 97 14 1 23 18 0-87 16 0 90 10 1-21
77 0 99
22 0-62 13 1 09 17 0-87 1 1 0 70 1 0-18
64 0-72
17 0.99 9 1-32 18 1.53 10 0.99 2 0-47
56 1-12
56 1-02 23 1-30 16 0-64 26 1-25 4 0-54
125 099
Table 11 Deathsfrom all causes, and incidence ofall cancer and lung cancer among a selected group of2025 short term employees ( < 18 months), employed before I January 1970 atfive of the plants)
Total mortality Cancer, all sites Lung cancer Lung cancer, plant D
*p < 0-05, **p < 0-01.
Observed
367 118 27
9
Expected
341 6 114-5 14 8
1.9
SMR-SIR
1-07 1-03 1.82* 4-66**
95% Cl (0-97-1-18) (0 86-123) (120-2 65) (2 17-8 99)
For the latest follow up period ( > 35 years), the SIRs decreased considerably. There was no selective excess of lung cancer among workers at plant A in any of the follow up periods.
During the planning of the study an internal reference series consisting of workers from all plants with less than 15 years of employment was established. Table 11 shows the overall mortality and incidence of all cancers and lung cancer. The observed excess of lung cancer in this group (SIR = 1-82) was most pronounced among employees at one of the ferromanganese plants (plant D), where nine cases of lung cancer were observed against 1-9 cases expected (SIR = 4 66). This result may indicate the presence of selection bias in the group, therefore they were not further used as an alternative reference series.
Discussion
The validity of the present results depends on several
conditions. Firstly, the incidence of cancer in the present cohort has been studied on the basis of retro-
spective experience. The possibility that previous
occurrence of cancer and death could have had a
bearing on the likelihood of becoming a member of the cohort must therefore be considered. In this study 742 subjects, representing 6% of the original cohort,
were not identified by a personal identification num-
ber and were thereby lost for follow up. If there is an excess of deaths and cases of cancer in this group compared with the remaining cohort the mortality and incidence of cancer in the ultimate cohort may have been underestimated. Such outcome dependent cohort admissibility represents a serious threat to studies based on retrospective experience.
The possibility of a selective loss of cases of cancer
in the present cohort seems highly unlikely, although a selective loss of deaths cannot be completely ruled out. Of those lost to follow up, 282 were employed less than 1-5 years, which implies that the loss of "rel-
234
evant" persons in relation to occupational cancer is less than indicated in table 2. The unidentified workers were evenly distributed among the subcohorts, indicating that no particular loss from one or a few of the subcohorts had taken place. For the subcohort from plants C and D there was initially some doubt as to the completeness of the oldest cohort segments. Tentative exclusion of these segments gave lower SMRs, which does not support the possibility of a selective loss of deaths in this group, but rather reflects the "active worker effect" as the main ingredient of the healthy worker effect.'5 The observed deficit in overall mortality (SMR = 0 90) and incidence of cancer (SIR = 0-94) is not greater than what might be expected owing to the positive health selection of industrial workers that may be reflected in studies of this design. Furthermore, as five of the six subcohorts have been formed as inception cohorts (table 1), a mainly primary healthy worker effect could have been operating in the cohort.'3 16 Any bias due to outcome selective cohort admissibility seems therefore to have been negligible in the present
study. Regarding previous studies of the incidence of can-
cer in the Scandinavian ferroalloy industry, Langard et al found seven cases of lung cancer (3-1 expected)
among ferrochromium workers but no cases among ferrosilicon workers (2-8 expected).7 A study from a Swedish ferrochromium plant showed no excess of
respiratory cancer (O/E = 5/7.2), but two mesotheliomas were found among maintenance workers.8 In a small cohort of ferrosilicon/ferrovanadium
workers there was one case of lung cancer versus 2-7 expected (J Alexander, Cairo conference). Thus so far there has been no indication of an increased risk of lung cancer associated with the production of
ferroalloys other than ferrochromium. Although the production of ferrosilicon and ferro-
manganese is associated with exposure to various particles and gases, only a few of these components are known to be carcinogenic. The most relevant exposure in relation to lung cancer in this study would seem to be exposure to asbestos and polycyclic aromatic hydrocarbons. Furnace workers and maintenance workers are the groups most likely to be exposed to these agents. There is no overall excess of lung cancer in these groups, nor in the subgroup of long term employees. The absence of a dose-response relation, however, is rather non-informative, as the employment period used in this study as an indicator of exposure time overlaps the follow up period.'7
Considering the asbestos consumption in the plants, the observed normal incidence of lung cancer among furnace and maintenance workers might be somewhat surprising. The result might indicate that the asbestos exposure to the individual worker has
Kjuus, Andersen, Langard, and Knudsen
been quite low, or just that the subgroup with relevant exposure is small and has not been properly identified. Two mesotheliomas occurred among the
workers in the original cohort. One of these cases, however, had been employed for less than one year,
and had had long lasting exposure to asbestos in
another industry. Based on the few measurements of PAH around
the ferroalloy furnaces at two of the study plants, the individual furnace worker has been only sporadically
exposed to PAH, presumably at a level below 10
yg/m3, for most working operations. The exposure
also seems to be lower than that reported from the Norwegian aluminium industry, which also uses the Soderberg electrode, and where a twofold excess of
lung cancer has been observed.'8
At one of the ferrosilicon plants (plant A) an excess
of lung cancer was observed (17 cases observed against 9-7 expected). Five of these were found among furnace workers (2-66 expected). The production process at this plant is similar to that of the other ferrosilicon plants, but plant A has in addition an anode paste plant, which produces anode paste for the Soderberg electrodes for the whole industry. This production involves exposure to polycyclic aromatic
hydrocarbons at levels in the range of 2-20 pg/m3
(KE Knudsen, personal communication). The occurrence of three cases of lung cancer among the anode paste workers (1 1 expected) is therefore notable. Additional information from the plant and the relatives of the patients with cancer showed no other relevant occupational exposures among the 17 cases of lung cancer, except for two workers who had been employed at a neighbouring nickel refinery. They had worked six and seven years at the nickel refinery respectively, one within 10 years before the cancer diagnosis, the other intermittently five to 30 years before diagnosis. In regard to sinonasal cancer, two of the five cases observed in the cohort were from plant A, and one of these had also been working at
the nickel refinery.'9
Information about smoking habits among the
cohort members in earlier times is not known. In the period 1977-83, however, information on smoking status was obtained from a sample of present employees at four of the plants (table 12). If the slightly higher smoking prevalence observed in the factory workers in this period compared with the general population reflects past differences in smoking habits between the groups a modest increase in the incidence of lung cancer could be expected in the cohort because of this difference.20 The observed incidence of lung cancer in five of the subpopulations, however, does not support the suggestion of smoking as a confounder of importance in these subcohorts. As the smoking habits among employees at plant A seem to
Cancer incidence among workers in the Norwegian ferroalloy industry
235
Table 12 Percentage daily smokers among employees atfour ofthe plants in 1977-83, compared with the general male population*
Year Study plants
Plant No ofemployees
% daily smokers
1977-78 1983
B,C,E A
631 577
52 47
*Based on figures from the National Council on Smoking and Health.
General male population (% daily smokers)
Age 16-74
Age 25-64
45 47 42 46
have been similar to the rest of the cohort, it is less likely that the observed excess of lung cancer at plant A can be explained by more smoking in previous years among the employees in this subcohort. Occupational exposure factors might therefore have contributed to the observed excess of lung cancer among the workers at this plant.
The statistically significant deficit of stomach can-
cer in this cohort is consistent for all subcohorts (table 5), with SIRs ranging from 049 to 0-88. A deficit of stomach cancer was also found among long term employed Swedish ferrochromium workers,8 whereas the incidence in the Norwegian ferrochromium
cohort was as expected.7 As the ferroalloy plants, at least in previous years, must be considered as typi-
cally polluted workplaces, these findings are in contrast with previous observations of a relation between polluted workplaces and the development of stomach
cancer2" (C A Veys, paper at XXI International Con-
gress on Occupational Health, Dublin, 1984). On the other hand, we are-not aware of any occupational factors in this industry that could possibly prevent stomach cancer, and there is no relation between the
observed cancer deficit and the duration of employment in this study (table 7). The regional variations in
the incidence of cancer may explain the result to some
extent, as the counties in which the study plants are located had a deficit of 9% of stomach cancer for the period 1972-6 compared with the national incidence.22 A possible exclusion from shiftwork of persons with gastric symptoms might also have con-
tributed to the observed result.
The higher than expected incidence of colonic can-
cer in the subcohort at plant C and of prostatic cancer in the subcohort at plant A is statistically of borderline significance, the 95% confidence intervals for both SIRs include unity. Although occupational factors may have contributed to this excess, the possibility of a type I error is also close at hand, bearing in mind the many independent comparisons performed in this study.23
In the case of renal cancer the previously reported
excess among ferrosilicon/ferrovanadium workers (O/E = 4/0 9) (J Alexander, Cairo conference) has not been confirmed in the present study (SIR = 0 90).
As a potential excess mortality or morbidity from a
certain disease can be hidden in the internal structure
of a cohort,24 the material was stratified according to period of entry and period of follow up. Assuming an average latent period of 20-30 years for occupational
cancers, the follow up period 25-35 years would be of
particular interest in the present study. As the exposure to dust and fumes is assumed to have been
higher in previous years, the observed excess of lung
cancer (O/E = 18/11-3) and of colonic cancer
(O/E = 12/6-7) among subjects employed before 1950
for the follow up period 25-34 years is notable. Neither of these SIRs is statistically significant, how-
ever, and a further interpretation of these results is
hampered by small figures in each cell.
The choice of a proper reference population is always a matter of concern in cohort studies such as the present one. The inherent problems of using
national figures for comparison are well known. We
aimed therefore at forming an alternative reference
group of short term employees, which somewhat surprisingly was found to have a significant excess of lung cancer (SIR = 1-82). Further information showed a distinctive recruitment pattern of migrant workers to short term employment at several of the plants in the 1930s and 1940s, including subjects with a life style, and presumably also smoking habits, different from the general population. At plant D,
where nine cases of lung cancer were observed (1.9 expected), most of the short term employees were seamen having short working periods on land.
Seamen in Norway have smoked more and have been reported to have an extreme excess of lung cancer
compared with the general population.25 This group
was therefore not further used as a reference group. Owing to the considerable regional variations of
many cancers,22 the cancer incidence rates of the county in which each plant is located could also be an alternative reference entity. When using county rates
for the incidence of lung cancer for 1972-6 as reference for the respective subcohorts, a change in SIR occurred for employees at plant A from 1-75 to 1 58 (95% CI: 0-92-2-51) and for employees at plant B from 0-69 to 110. There were only small adjustments for the other plants. Nevertheless, as other identified occupational groups with excess lung cancer might have contributed to the 11% excess lung cancer
236
observed in the county where plant A is located,'9 the county figures for lung cancer in this study would not necessarily be more representative for an unexposed reference population than the national incidence rates.
In the light of the many non-positive results presented the statistical power of the study really to detect a true increase in the incidence of cancer should be considered. Given a type I error (x) = 0-05 and
type II error (/) = 0 20, an expected figure of nine or
more would have been required for each association studied to detect a twofold increase in the risk of cancer.26 Similarly, an expected figure of 32 or more would be necessary for detecting a 50% excess in the risk of cancer. This would imply that more than a twofold increase in the incidence of cancer for most of the cancers studied among the members of this cohort is unlikely. For rare cancer locations, however, or for cancer occurring in particular subgroups of the cohort, such an excess would not necessarily have been shown. The statistical power of the study must therefore be borne in mind when its non-positive results are evaluated.
This project has been financed by the Health Board of Norwegian Ferroalloy Industry. Unni Danielsen and Patricia Flor helped prepare this manuscript.
References
1 Roberts WC. The ferroalloy industry. Hazards of the alloys and semimetallics: part I. J Occup Med 1965;7:30-6.
2Roberts WC. The ferroalloy industry. Hazards of the alloys and
semimetallics: part II. J Occup Med 1965;7:71-7. 3Bruce T. The occurrence of silicosis in the manufacture of silicon
alloys. J Ind Hyg Toxicol 1937;19:155-62. 4Broch C. An investigation of the occurrence of silicosis in a plant
for fusing ferrosilicon and ferrochromium. Nord Hyg Tidskr 1949;1:1-7. (In Norwegian. English abstract. J Ind Hyg Toxicol 1949;31:97.)
'Tanaka S, Lieben J. Manganese poisoning and exposure in Penn-
sylvania. Arch Environ Health 1969;19:674-84.
'Cook DG, Brait KA. Chronic manganese intoxication. Arch Neu-
rol 1974;30:59-64.
'Langard S, Andersen A, Gylseth B. Incidence of cancer among
Kjuus, Andersen, Langard, and Knudsen
ferrochromium and ferrosilicon workers. Br J Ind Med 1980;37: 114-20. 'Axelsson G, Rylander R, Schmidt A. Mortality and incidence of tumours among ferrochromium workers. Br J Ind Med 1980;37: 121-7. 9Dalgaard JB, Gregersen M. Risk of poisoning during trans-
portation of ferrosilicon by ship. Nord Med 1964;71:271-3. (In Norwegian. English abstract.) ' Bjorseth A, Bj0rseth 0, Fjeldstad PE. Polycyclic aromatic hydrocarbons in the work atmosphere. II Determination in a coke plant. Scand J Work Environ Health 1978;4:224-36. l Bj0rseth A, Bj0rseth 0, Fjeldstad PE. Polycyclic aromatic hydrocarbons in the work atmosphere. I Determination in a aluminium reduction plant. Scand J Work Environ Health 1978; 4:212-23. 12 Feinstein A. Clinical biostatistics. St Louis: CV Mosby,
1977:74-104. Weiss W. Heterogeneity in historical cohort studies: a source of
bias in assessing lung cancer risk. J Occup Med 1983;25:290-4. 14Miettinen 0. Estimability and estimation in case-referent studies.
Am J Epidemiol 1976;103:226-35. 15Wen CP, Tsai SP, Gibson RL. Anatomy of the healthy worker
effect: a critical review. J Occup Med 1983;25:283-9. 16Olsen J, Sabroe S. Researching occupational mortality: the prob-
lem of comparison. Scand J Soc Med 1979;7:1-6. 17 Enterline PE. Pitfalls in epidemiological research: an examination
of the asbestos literature. J Occup Med 1976;18:150-6. 18Andersen A, Dahlberg BE, Magnus K, Wannag A. Risk of cancer
in the Norwegian aluminium industry. Int J Cancer 1982;29:295-8. "Pedersen E, H0getveit AC, Andersen A. Cancer of respiratory organs among workers at a nickel refinery in Norway. Int J Cancer 1973;12:32-41. 20Axelson 0. Aspects on confounding in occupational health epidemiology. Scand J Work Environ Health 1978;4:85-9. 21 Meyer MB, Luk GD, Sotelo JM, Cohen BH, Menkes HA. Hypothesis: the role of the lung in stomach carcinogenesis. Am Rev Respir Dis 1980;121:887-92. 22 Cancer Registry of Norway. Geographical variations in cancer incidence in Norway 1966-1975. Oslo: Landsforeningen mot Kreft, 1978. 23Dinman BD, Sussman NB. Uncertainty, risk, and the role of epidemiology in public policy development. J Occup Med 1983;25:51 1-6. 24 Koskela RS, Jarvinen E, Kolari PJ. Effect of cohort definition and follow-up length on occupational mortality rates. Scand J Work Environ Health 1984;10:311-6.
2S Baksaas I, Lund E, Skjerven JE, Langard S, Vellar OD, Aar0 LE. Cancer among merchant seamen: a cohort study. Tidsskr Nor
Laegeforen 1983;103:2317-20. (In Norwegian. English abstract.) 26 Haines T, Shannon H. Sample size in occupational mortality stud-
ies. J Occup Med 1983;25:603-8.